Skip to main content
Head and Neck Pathology logoLink to Head and Neck Pathology
. 2020 Apr 25;15(1):303–310. doi: 10.1007/s12105-020-01162-y

Aggressive Intraosseous Myofibroma of the Maxilla: Report of a Rare Case and Literature Review

John Lennon Silva Cunha 1, Carla Isabelly Rodrigues-Fernandes 1, Ciro Dantas Soares 1, Celeste Sánchez-Romero 1,2, Pablo Agustin Vargas 1, Cleverson Luciano Trento 3, Bruno Augusto Benevenuto de Andrade 4, Sílvia Ferreira de Sousa 5, Ricardo Luiz Cavalcanti de Albuquerque-Júnior 6,
PMCID: PMC8010050  PMID: 32335819

Abstract

Myofibroma (MF) is a benign mesenchymal myofibroblast-derived tumor, which occurs most frequently in children, and rarely affects the maxilla. We reported a case of an aggressive intraosseous lesion found in the maxilla of a 9-year-old female child. Intraorally, the swelling extended from tooth 12 to 16, causing displacement of teeth 13, 14, and 15. Computed tomography revealed a large osteolytic lesion causing thinning and cortical erosion. Microscopically, the lesion showed a proliferation of spindle-shaped cells, with elongated nuclei and eosinophilic cytoplasm, arranged in interlaced fascicles. The immunohistochemical analysis revealed cytoplasmic positivity for α-SMA and HHF-35, and negativity for desmin, laminin, S-100, β-catenin, and CD34. Ki-67 was positive in 8% of tumor cells. The diagnosis was MF. Herein, we describe an additional case of central MF arising in the maxilla, including clinical, imaging, microscopical, and immunohistochemical features, as well as a review of the literature.

Keywords: Myofibroma, Jaws, Maxilla, Pediatrics

Introduction

Myofibromas (MF) are rare benign mesenchymal neoplasms. Although considered a childhood neoplasm, MF can occur at any age and is the solitary counterpart of myofibromatosis [1, 2]. MF involve more frequently the subcutaneous tissues of the head and neck (approximately one-third of all cases) [2, 3], and involvement of the oral cavity is uncommon, particularly centrally in the maxilla [3, 4]. When they occur in oral tissues, the mandible (intraosseous) is the most affected anatomic site, followed by the buccal mucosa, posterior mandible alveolar mucosa/retromolar region, tongue, and labial mucosa [4].

To the best of our knowledge, only six cases of central myofibromas affecting the maxilla have been reported in the English-language literature, including the current case (Table 1) [59]. In view of the rarity of these lesions in maxilla, the diagnosis may cause confusion with other benign mesenchymal lesions, or even with low-grade malignant spindle cell neoplasms [10, 11]. Therefore, the establishment of a correct diagnosis is crucial for a proper treatment approach [11]. Herein, we describe a case of central MF in the maxilla, including clinical, imaging, microscopical, and immunohistochemical features, as well as a review of the literature.

Table 1.

Summary of previous cases of solitary intraosseous myofibromas affecting the maxilla

Case Author Age (years)b Gender Localization Size (cm) Symptoms Treatment Follow up time (months) Recurrence Trauma Immunohistochemistry performed
1 Fushimi et al. [5] 57 F

Anterior

Maxilla

2,0 × 1,0 × 1,5 No Resection and extraction of resorbed teeth associated with the lesion 24 No NR α-SMA + , Vimentin + , S-100 − , Desmin -
2 Damera et al. [6] 13 F

A–P

Maxilla

NR No NR 24 No NR α-SMA + , Vimentin + , S-100 − , Desmin − , HHF-35 + 
3 Tabrizi et al. [7] 1 M Posterior Maxilla 4,5 × 3,0 NR Enucleation 18 No Yes α-SMA + , HHF-35 + , Desmin − 
4 Nashef et al. [9] 9 F A–P Maxilla 2,0 × 3,0 No Partial maxillectomy and peripheral ostectomy 8 No NR α-SMA + , Desmin − , CD34 -, CD39 − , H-caldesmon − , Factor XIIIa -
5 Kaur et al. [8]a 12 F

A–P

Maxilla

5,0 × 6,0 No Enucleation NR No NR α-SMA + , Vimentin + , S-100 − , Ki-67 − , Focal positivity for desmin
6 Present case 9 F

A–P

Maxilla

3,5 × 2,0 No Enucleation and curettage 36 No No

α-SMA + , Desmin -, β-catenin -, Laminin − , S-100 − ,

CD34 − , Ki-67 < 10%

NR not reported, F female, M male, A-P anterior and posterior region

aDoes not provide histological images of the case

bAge at time of diagnosis

Case Report

An otherwise healthy 9-year-old female was referred to the oral medicine service of the School of Dentistry at the Federal University of Sergipe, with a chief complaint of a painless swelling in the right maxilla with a duration of approximately 4 months. There was no history of previous trauma in the region, and the past medical history was not contributory. The extraoral examination showed a slight swelling on the right side of the face and cervical lymph node alterations were not observed. The intraoral examination revealed a swelling in the right maxillary region covered by normal-colored mucosa with focal ulceration, measuring approximately 3 cm in diameter, extending from tooth 12 to 16, and causing displacement of teeth 13, 14 and 15 (Fig. 1). The lesion had a rubbery consistency on palpation and was asymptomatic, except for slight discomfort due to tumor growth.

Fig. 1.

Fig. 1

Clinical appearance of the lesion

Cone-beam computed tomography (CT) (Fig. 2) demonstrated, in a panoramic reconstruction, the presence of a hypodense lesion with poorly defined limits, located in the right posterior maxilla, causing perforation of buccal and lingual cortical plates. A provisional diagnosis of osteosarcoma was established, and an incisional biopsy was performed. The biopsy specimen was submitted to histopathological analysis.

Fig. 2.

Fig. 2

Cone-beam computed tomography (CT). A and B. Presence of an ill-defined hypodense lesion in the right posterior maxilla (axial sections). C. 3D reconstruction showing loss of lingual and vestibular cortical continuity

Gross examination revealed a soft tissue fragment with a firm and rubbery consistency and a yellowish surface, measuring 1.3 × 1.1 × 0.5 cm (Fig. 3). On a cross-section, the surgical specimen showed a glistening white surface with patchy areas of hemorrhage. Morphological analysis revealed spindle-cell proliferation, forming intersecting fascicles of variable length, or in a haphazard arrangement. In a low-power view, a slight biphasic pattern of lighter-stained and darker-stained areas (zoning phenomenon) was observed. Tumor cells exhibited elongated vesicular nuclei with two or more inconspicuous nucleoli and eosinophilic cytoplasm of indistinct boundaries, compatible with myofibroblast morphology. In focal peripheral regions, associated with ulceration, a mixed inflammatory infiltrate was observed; however, it was not present in the rest of the tumor. In the central areas of the sample, large thin-walled vessels with “stag-horn” morphology were noted. Although some neoplastic cells presented slightly hyperchromatic nuclei, the mitotic index was low, and tumor necrosis was not observed (Fig. 4).

Fig. 3.

Fig. 3

Macroscopic appearance of the biopsy specimen

Fig. 4.

Fig. 4

Histopathologic features of MF (hematoxylin and eosin stain). a and b Proliferation of spindle-shaped cells arranged in intersecting fascicles or in a haphazard pattern (original magnification a × 100, b × 200). c Detail of thin-walled blood vessels with a hemangiopericytoma-like pattern original magnification × 400). d Myofibroblasts with a characteristic spindle or stellate shape, pale or vesicular nuclei, small nucleoli, and eosinophilic cytoplasm. Occasional mitoses are observed (arrowhead) (original magnification × 400)

Immunohistochemical analysis was performed for confirmation of the myofibroblastic phenotype of tumor cells. The tumor cells were strongly positive for α-SMA and HHF35, and negative for desmin, laminin, S-100, and β-catenin. Positivity for CD34 was limited to the vascular network, and the positivity for Ki-67 was seen in approximately 8% of parenchymal cells (Fig. 5). Based on clinical, histopathological, and immunohistochemical findings, a diagnosis of MF was established.

Fig. 5.

Fig. 5

Immunohistochemical features of MF. a Tumor cells showing strong positivity for a-smooth muscle actin (original magnification × 200). b Positive immunohistochemical staining for HHF-35 (original magnification × 200). c Ki-67 (MIB-1) labeling index is approximately 8% (original magnification × 200)

The patient was referred for enucleation and curettage of the lesion, and no recurrence was observed after 3 years of follow-up. Prosthetic rehabilitation with implants will be performed after the maxillofacial bones attained complete growth. The patient is currently undergoing routine follow-up.

Discussion

To date, only six cases of intraosseous myofibromas affecting the maxilla have been reported in the English-language literature, including the current case. The overall information for the 6 cases is displayed in Table 1. According to these cases [59], most of the patients were children or adolescents and females, which is an agreement with our case. However, a well-documented case has been reported in a 57-year-old patient [5], which suggests that the diagnosis of MF must also be considered in cases of neoplasms of the maxilla even in older patients. In addition, racial predisposition was not observed. Abramowicz et al. (2012) reported 2 intraosseous MF in the maxilla. However, accurate information on individual cases has not been provided and for this reason were not included in the present study [12].

When the jaws are involved, MF present as a painless destructive osteolytic lesion, with well-defined borders, and slow growth [4, 1315] (Table 2). Extensive lesions may cause expansion, thinning, and perforation of the cortical plates, mimicking the biological behavior of a wide range of intraosseous diseases, from odontogenic tumors to malignant neoplasms [1, 13, 14, 16]. Clinical signs and symptoms mainly depend on the affected anatomical site and vary considerably. The typical clinical presentation in the head and neck region is a painless swelling [4, 14, 16]; however, it may present ulceration, and sometimes, display a rapid growth mimicking malignant tumors and thus becoming alarming [13, 15]. However, most of these cases did not show rapid growth, as observed in the present case. The spectrum of clinical presentation suggests that MF may present variation in biological behavior [13]. Furthermore, other signs and symptoms have been reported, such as proptosis, nasal obstruction, and nasal discharge [16].

Table 2.

Imaging features of the previously reported myofibromas affecting the maxilla

Case Author Imaging Borders Internal structure Locularity Effects on teeth Expansion Cortical perforation Periosteal reaction
1 Fushimi et al. [5] Panoramic X-ray, CT, MR, BC WD RL, LA, T2S U D, R Y NV NR
2 Damera et al. [6] Panoramic X-ray, CT (n/a) ID RL, LA, Ca U D, R Y Y NR
3 Tabrizi et al., 2013 CT WD LA U NR Y Y NR
4 Nashef et al. [7] Panoramic X-ray, CT WD RL, LA U D Y Y NR
5 Kaur et al. [8] Panoramic X-ray, CT WD RL, LA U D Y Y NR
6 Present case Panoramic X-ray, CT ID RL, LA U D Y Y NV

NR not reported, BC bone scintigraphy, CT computed tomography, MR magnetic resonance Imaging, WD well-defined, ID ill-defined, RL radiolucent, LA low-attenuation, Ca calcification, T2S hyperintense T2 MR Signal, U unilocular, M multilocular, D root displacement, R root resorption, Y yes, NV not visualized

The rare occurrence of MF in the oral cavity, particularly in the maxilla, and the morphological similarity with other malignant or benign mesenchymal lesions can make the diagnosis challenging [7, 14]. In addition, misdiagnosis may occur, leading to an improper therapeutic approach [5, 7, 1416]. In fact, several cases published in the literature were initially diagnosed as other diseases [12, 14, 15, 17]. Early diagnosis and surgery are important for preventing subsequent deformity and eventual destruction of anatomic structures in children and adolescents [7]. Thus, careful histological and immunohistochemical evaluation is mandatory to avoid incorrect diagnosis and unnecessary radical surgery [10, 14].

Other fibromatoses, particularly desmoid fibromatosis (DF), nodular fasciitis (NF), inflammatory myofibroblastic tumor, solitary fibrous tumor (SFT), neurofibroma, and smooth muscle tumors should be considered in the differential microscopical diagnosis [3, 4, 14]. Moreover, some low-grade spindle cell sarcomas such as low-grade myofibroblastic sarcoma (LGMS), infantile fibrosarcoma, and leiomyosarcoma might also be confused with MF [18]. Thus, immunohistochemical analysis is helpful to confirm the myofibroblastic phenotype of the neoplastic cells and the benign nature of the tumor [11, 14, 15].

A panel of antibodies for desmin, h-caldesmon, s-100, and α-SMA antigen detection has been suggested to distinguish MF from neural and smooth-muscle tumors [4, 15]. In addition, the use of vascular markers, such as CD31 and CD34, may be used to exclude SFT [14]. On the other hand, β-catenin and Ki-67 immunoexpression could be helpful to perform the differential diagnosis with some aggressive fibromatosis (desmoid tumors) and malignant tumors of the connective tissue [3, 11, 18].

Nodular fasciitis was considered in our case; however, NF is a self-limiting disease considered by many to be a reactive process and rarely observed in newborns and children [19]. In addition, oral lesions are uncommon, especially in intraosseous sites. Also, the lesion did not exhibit a prominent myxoid matrix, dispersed chronic inflammatory infiltrate, extravasated red blood cells, findings often described in these lesions [14, 15, 18]. The tumor also presented a hemangiopericytoma-like vascular pattern, which is not observed in NF [14]. However, recent studies have identified recurrent USP6 gene rearrangements in most cases, often with MYH9 as the fusion partner (~ 70%) [2022], firmly establishing its neoplastic nature [11, 18].

Differentiation from SFT may also be difficult because of the hemangiopericytoma-like vascular appearance shared by both lesions; nevertheless, MF exhibiting this prominent vascular pattern can be distinguished from SFT by the denser spindle-cell component, biphasic pattern, and immunohistochemical positivity for α-SMA [14, 15]. In addition, recent studies have identified recurrent NAB2-STAT6 gene fusions in nearly all SFTs [2326]; subsequent multiple researchers have confirmed that nuclear STAT6 immunohistochemical reactivity is highly specific for SFT [2632] and is a reliable marker to differentiate SFT from MF and other histologic mimics [18, 26, 31]. Smooth muscle-derived tumors, such as leiomyomas, may also resemble MF [14, 15]; however, intraosseous leiomyomas are extremely rare [15] and exhibit immunopositivity for desmin and/or laminin [14], which has not been described in MF, as observed in the current case. In addition, h-caldesmon has been a useful immunohistochemical marker to differentiate between leiomyomas and MF [4, 33].

Differentiation of desmoid fibromatosis can also be a challenge, especially because both lesions show positive staining for vimentin and variable expression for smooth muscle actin [14]. However, DF is usually more collagenous and less cellular than MF, exhibit slender fibroblasts in long fascicles and infiltrative growth pattern [11, 18]. In addition, about 85% of cases of fibromatoses show positive nuclear staining for the β-catenin result of mutations in the gene encoding β-catenin (CTNNB1) [10, 11, 18], unlike our case that was β-catenin negative. Thus, nuclear immunostaining for β-catenin is useful in distinguishing fibromatoses from other similar spindle cell lesions [11].

On the other hand, interestingly, some MF may exhibit infiltrative margins, cytologic atypia, and increased mitotic activity, which may lead to a misdiagnosis of malignancy [4, 14]. Leiomyosarcoma and low-grade myofibroblastic sarcoma, in particular, may show a similar infiltrative pattern, but differently of MF, present a less uniform morphology, exhibiting cytological atypia and frequently shows positivity for desmin [14]. Congenital/infantile fibrosarcoma (IF) may also resemble MF; however, fibrosarcomas are uncommon tumors of the oral cavity and exhibit well-organized fusiform cells in a herringbone pattern, moderate to high cellularity and nuclear atypia, increased mitotic figures, hemorrhage, necrosis, and infiltrates adjacent soft tissue with irregular margins [16], features not commonly observed in MF. Also, IF are tumors of infancy traditionally associated with the ETV6–NTRK3 gene fusion [34].

In the present case, discrete areas of cell atypia were observed, which raised the suspicion of a possible LGMS, especially when correlating with the clinical characteristics and short evolution time of the lesion. LGMS is a rare relatively indolent myofibroblastic neoplasm that tends to arise in the head and neck region and extremities and occasionally metastasizes [11, 18]. Most of the cases arise between the fourth and fifth decades of life, and rarely are intraosseous. In the oral cavity, the tongue is the most affected site [18]. Histologically, LGMS consist of atypical spindle-shaped tumor cells with fusiform nuclei and eosinophilic cytoplasm arranged in fascicles or storiform architecture with an infiltrative growth pattern, the stroma shows variable grades of collagenization/hyalinization [11, 18]. Although LGMS has been included in our differential diagnosis, the low rate of cell proliferation (assessed by Ki-67), low mitotic index, absence of necrosis, and negativity for desmin were valuable information to rule out this possibility. In addition, the typical biphasic pattern of the myofibroma (zoning phenomenon) is not observed in LGMS. Although genetic analyses were not performed in this case, it must be considered that between both tumors, the genetic alterations differ (myofibroma: recurrent somatic PDGFRB mutations; LGMS: cytogenetic or molecular genetic alterations have not been described so far) [18, 35, 36].

In summary, solitary intraosseous MF present a benign clinical course, with slow growth and cure after complete conservative surgical excision [3, 4, 37]. Although some cases presented rapid growth [3], as observed in the present case, some lesions showed spontaneous regression [38], and some remained stable after partial excision [39]. In the previous cases [59] and the present case involving maxilla, the follow-up time ranged from 8 to 36 months (17.2 ± 7.15, mean ± SD), and no recurrences were reported. Although most published cases have a short follow‐up, recurrences are rarely observed in solitary MF affecting other anatomical sites [14], even when only curettage was the treatment used. However, newborns with multiple tumors (congenital infantile myofibromatosis) have a mortality rate of more than 70% [4], and often die at birth or soon after birth due to complications associated with tumor growth [3], by which, is considered a different entity from solitary MF. Thus, it is important to exclude multifocal or multicentric disease, since the prognosis for multicentric disease is much worse than for isolated cases [40].

Conclusions

In conclusion, solitary intraosseous MF involving the maxilla are very rare. The correlation of the clinical, histopathological, and immunohistochemical features are necessary for the correct diagnosis and avoid radical surgical interventions with associated morbidity. Although rare, the MF of maxilla should be considered in the differential diagnosis of unilocular radiolucent lesions presenting undefined limits in children and adolescents.

Funding

No funding sources to disclose.

Compliance with Ethical Standards

Conflict of interest

No conflicts of interest to disclose.

Ethical Approval

For this type of retrospective case report, formal consent is not required.

Informed Consent

No identifier information is included in the case report, and the study meets the waiver criteria for the institutional review board of School of Dentistry of Piracicaba.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.White D, Franklin LA. Clinical Pathologic Conference Case 3: A 15-Year-Old Male With a Radiolucent Jaw Lesion. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(6):e295–e297. doi: 10.1016/j.oooo.2014.11.023. [DOI] [PubMed] [Google Scholar]
  • 2.Al Qawahmed R, Sawyer SL, Vassilyadi M, Qin W, Boycott KM, Michaud J. Infantile myofibromatosis with intracranial extradural involvement and PDGFRB mutation: a case report and review of the literature. Pediatr Dev Pathol. 2019;22(3):258–264. doi: 10.1177/1093526618787736. [DOI] [PubMed] [Google Scholar]
  • 3.Lopes RN, Alves de AF, Rocha AC, Suassuna TM, Kowalski LP, de Castro JF, Perez DE. Head and neck solitary infantile myofibroma: clinicopathological and immunohistochemical features of a case series. Acta Histochem. 2015;117(4–5):431–436. doi: 10.1016/j.acthis.2015.02.001. [DOI] [PubMed] [Google Scholar]
  • 4.Smith MH, Reith JD, Cohen DM, Islam NM, Sibille KT, Bhattacharyya I. An update on myofibromas and myofibromatosis affecting the oral regions with report of 24 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124(1):62–75. doi: 10.1016/j.oooo.2017.03.051. [DOI] [PubMed] [Google Scholar]
  • 5.Fushimi K, Shiiba M, Kouzu Y, et al. Central myofibroma of the maxilla: a case report. J Oral Maxillofac Surg Med Pathol. 2015;27(1):78–83. doi: 10.1016/j.ajoms.2013.08.006. [DOI] [Google Scholar]
  • 6.Damera NCR, Vallabhaneni KC, Tripuraneni SC, Madala S, Diddi RR. Non malignant maxillary lesions: our experience. Indian J Otolaryngol Head Neck Surg. 2013;65(SUPPL 1):74–79. doi: 10.1007/s12070-012-0531-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Tabrizi R, Bahramnejhad E, Kazemi H, Asadzadeh M, Ranjbaran H. Rapidly growing lesions involving the maxilla in infants: a two-case presentation and deferential diagnosis. J Craniofac Surg. 2013;24(4):e434–e438. doi: 10.1097/SCS.0b013e3182942e18. [DOI] [PubMed] [Google Scholar]
  • 8.Kaur P, Chowalta R, Lata J. Central myofibroma of the maxilla. Contemp Clin Dent. 2016;7(1):71–74. doi: 10.4103/0976-237X.177109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Nashef R, Fleissig Y, Abu-tair J, Heyman O, Doviner V. Solitary central myofibroma of the maxilla: a case report. J Oral Maxillofac Surg Med Pathol. 2014;26(4):558–562. doi: 10.1016/j.ajoms.2013.06.010. [DOI] [Google Scholar]
  • 10.Pereira de Oliveira DHI, da Silveira ÉJD, de Souza LB, Caro-Sanchez CHS, Dominguez-Malagon H, Mosqueda Taylor A, Queiroz LMG. Myofibroblastic lesions in the oral cavity: immunohistochemical and ultrastructural analysis. Oral Dis. 2019;25(1):174–181. doi: 10.1111/odi.12972. [DOI] [PubMed] [Google Scholar]
  • 11.Choi JH, Ro JY. Recent advances in fibroblastic/myofibroblastic tumors. AJSP. 2017;22(2):124–134. [Google Scholar]
  • 12.Abramowicz S, Simon LE, Kozakewich HP, Perez-Atayde AR, Kaban LB, Padwa BL. Myofibromas of the jaws in children. J Oral Maxillofac Surg. 2012;70(8):1880–1884. doi: 10.1016/j.joms.2011.09.029. [DOI] [PubMed] [Google Scholar]
  • 13.Castro HHO, Gomes HE, Tassara LFR, de Freitas JB, de Grandinetti HAM, Capistrano HM. Myofibroma of the mandible—case report. Pediatr Dent J. 2016;26(1):38–41. doi: 10.1016/j.pdj.2015.12.002. [DOI] [Google Scholar]
  • 14.Brierley DJ, Khurram SA, Speight PM. Solitary myofibroma of the adult mandible: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(3):e40–e43. doi: 10.1016/j.oooo.2012.05.012. [DOI] [PubMed] [Google Scholar]
  • 15.Satomi T, Kohno M, Enomoto A, Abukawa H. Solitary myofibroma of the mandible: an immunohistochemical and ultrastructural study with a review of the literature. Med Mol Morphol. 2014;47(3):176–183. doi: 10.1007/s00795-013-0062-8. [DOI] [PubMed] [Google Scholar]
  • 16.Dhupar A, Carvalho K, Sawant P, Spadigam A, Syed S. Solitary intra-osseous myofibroma of the jaw: a case report and review of literature. Children. 2017;4(10):E91. doi: 10.3390/children4100091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Foss RD, Ellis GL. Myofibromas and myofibromatosis of the oral region: a clinicopathologic analysis of 79 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89(1):57–65. doi: 10.1067/moe.2000.102569. [DOI] [PubMed] [Google Scholar]
  • 18.Baranov E, Hornick JL. Soft tissue special issue: fibroblastic and myofibroblastic neoplasms of the head and neck. Head Neck Pathol. 2020 doi: 10.1007/s12105-019-01104-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zhurakivska K, Troiano G, Montella M, Ronchi A, Di Stasio D, Cicciù M, Laino L. Surgical treatment of oral cavity nodular fasciitis. J Craniofac Surg. 2019 doi: 10.1097/SCS.0000000000005877. [DOI] [PubMed] [Google Scholar]
  • 20.Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013;463:97–98. doi: 10.1007/s00428-013-1418-0. [DOI] [PubMed] [Google Scholar]
  • 21.Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, et al. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011;91:1427–1433. doi: 10.1038/labinvest.2011.118. [DOI] [PubMed] [Google Scholar]
  • 22.Patel NR, Chrisinger JSA, Demicco EG, Sarabia SF, Reuther J, Kumar E, et al. USP6 activation in nodular fasciitis by promoterswapping gene fusions. Mod Pathol. 2017;30:1577–1588. doi: 10.1038/modpathol.2017.78. [DOI] [PubMed] [Google Scholar]
  • 23.Mohajeri A, Tayebwa J, Collin A, Nilsson J, Magnusson L, von Steyern FV, et al. Comprehensive genetic analysis identifes a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profle in solitary fbrous tumor. Genes Chromosom Cancer. 2013;52:873–886. doi: 10.1002/gcc.22083. [DOI] [PubMed] [Google Scholar]
  • 24.Robinson DR, Wu Y-M, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung Y-S, et al. Identifcation of recurrent NAB2-STAT6 gene fusions in solitary fbrous tumor by integrative sequencing. Nat Genet. 2013;45:180–185. doi: 10.1038/ng.2509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chmielecki J, Crago AM, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, et al. Whole-exome sequencing identifes a recurrent NAB2-STAT6 fusion in solitary fbrous tumors. Nat Genet. 2013;45:131–132. doi: 10.1038/ng.2522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol. 2014;27:390–395. doi: 10.1038/modpathol.2013.164. [DOI] [PubMed] [Google Scholar]
  • 27.Demicco EG, Harms PW, Patel RM, Smith SC, Ingram D, Torres K, Carskadon SL, Camelo-Piragua S, McHugh JB, Siddiqui J, Palanisamy N, Lucas DR, Lazar AJ, Wang WL. Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol. 2015;143(5):672–682. doi: 10.1309/AJCPN25NJTOUNPNF. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hornick JL. Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors. Mod Pathol. 2014;27(Suppl 1):S47–63. doi: 10.1038/modpathol.2013.177. [DOI] [PubMed] [Google Scholar]
  • 29.Koelsche C, Schweizer L, Renner M, Warth A, Jones DT, Sahm F, Reuss DE, Capper D, Knösel T, Schulz B, Petersen I, Ulrich A, Renker EK, Lehner B, Pfister SM, Schirmacher P, von Deimling A, Mechtersheimer G. Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour. Histopathology. 2014;65(5):613–622. doi: 10.1111/his.12431. [DOI] [PubMed] [Google Scholar]
  • 30.Vogels RJ, Vlenterie M, Versleijen-Jonkers YM, Ruijter E, Bekers EM, Verdijk MA, Link MM, Bonenkamp JJ, van der Graaf WT, Slootweg PJ, Suurmeijer AJ, Groenen PJ, Flucke U. Solitary fibrous tumor—clinicopathologic, immunohistochemical and molecular analysis of 28 cases. Diagn Pathol. 2014;9:224. doi: 10.1186/s13000-014-0224-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Smith MH, Islam NM, Bhattacharyya I, Cohen DM, Fitzpatrick SG. STAT6 reliably distinguishes solitary fibrous tumors from myofibromas. Head Neck Pathol. 2018;12(1):110–117. doi: 10.1007/s12105-017-0836-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Yoshida A, Tsuta K, Ohno M, Yoshida M, Narita Y, Kawai A, Asamura H, Kushima R. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol. 2014;38(4):552–559. doi: 10.1097/PAS.0000000000000137. [DOI] [PubMed] [Google Scholar]
  • 33.Ceballos KM, Nielsen GP, Selig MK, O'Connell JX. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study. Am J Clin Pathol. 2000;114(5):746–753. doi: 10.1309/K5JP-A9EN-UWN7-B5GG. [DOI] [PubMed] [Google Scholar]
  • 34.Flucke U, Karanian M, Broek RWT, Thway K. Soft tissue special issue: perivascular and vascular tumors of the head and neck. Head Neck Pathol. 2020 doi: 10.1007/s12105-020-01129-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Agaimy A, Bieg M, Michal M, Geddert H, Märkl B, Seitz J, Moskalev EA, Schlesner M, Metzler M, Hartmann A, Wiemann S, Michal M, Mentzel T, Haller F. Recurrent somatic PDGFRB mutations in sporadic infantile/solitary adult myofibromas but not in angioleiomyomas and myopericytomas. Am J Surg Pathol. 2017;41:195–203. doi: 10.1097/PAS.0000000000000752. [DOI] [PubMed] [Google Scholar]
  • 36.de Siqueira EC, de Sousa SF, Carlos R, de Andrade BAB, Romañach MJ, Gomez RS, Gomes CC. Odontogenic myxomas lack PDGFRB mutations reported in myofibromas. J Oral Pathol Med. 2020;00:1–6. doi: 10.1111/jop.13004. [DOI] [PubMed] [Google Scholar]
  • 37.Azevedo RS, Pires FR, Coletta RD, Almeida OP, Kowalski LP, Lopes MA. Oral myofibromas: report oftwo cases and review of clinical and histopathologic differential diagnosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:e35–40. doi: 10.1016/j.tripleo.2008.02.022. [DOI] [PubMed] [Google Scholar]
  • 38.Rubin BP, Bridge JA. Fibroblastic/myofibroblastic tumours. In: Fletcher CDM, Unni KK, Mertens F, editors. WHO classification of tumors. Pathology and genetics. Tumors of soft tissue and bone. Lyon: IARC; 2002. pp. 59–61. [Google Scholar]
  • 39.Vered M, Allon I, Buchner A, Dayan D. Clinico-pathologic correlations ofmyofibroblastic tumors ofthe oral cavity: II. Myofibroma and myofibromatosis of the oral soft tissues. J Oral Pathol Med. 2007;36:304–314. doi: 10.1111/j.1600-0714.2007.00528.x. [DOI] [PubMed] [Google Scholar]
  • 40.Mynatt CJ, Feldman KA, Thompson LD. Orbital infantile myofibroma: a case report and clinicopathologic review of 24 cases from the literature. Head Neck Pathol. 2011;5(3):205–215. doi: 10.1007/s12105-011-0260-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Head and Neck Pathology are provided here courtesy of Humana Press

RESOURCES